市場調查報告書
商品編碼
1500406
醫學影像市場:按模式、最終用戶、應用分類 - 2024-2030 年全球預測Medical Imaging Market by Modality (Computed Tomography, Fluoroscopy, Mammography), End-User (Diagnostic Centers, Hospitals), Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年醫學影像市場規模為540.5億美元,預計2024年將達612.2億美元,2030年將達1,391億美元,複合年成長率為14.45%。
醫學影像市場是醫療保健的關鍵支柱,提供複雜的技術來視覺化人體內部解剖結構,這對於診斷、治療和研究至關重要。市場成長的推動因素包括不斷提高影像品質和系統效率的技術進步、需要強大診斷解決方案的慢性疾病的增加、需要頻繁醫療服務的老年人口的增加以及對醫療保健基礎設施的需求增加,這些因素包括:重大政府投資。然而,醫學影像領域也面臨重大挑戰,包括與先進診斷影像系統相關的高成本、嚴格的監管條件以及對可能限制患者接觸的輻射暴露的擔憂。人工智慧的日益整合預計將提高診斷準確性,可攜式診斷成像設備的開發提高了可及性,診斷成像技術的進步最大限度地減少了輻射風險,從而提供了市場擴張機會。混合成像技術也正在成為一種創新趨勢,融合多種顯像模式以提高診斷效率和患者治療結果。
主要市場統計 | |
---|---|
基準年[2023] | 540.5億美元 |
預測年份 [2024] | 612.2億美元 |
預測年份 [2030] | 1391億美元 |
複合年成長率(%) | 14.45% |
區域洞察
在美洲,美國在研發 (R&D) 方面的大量投資的支持下,重點在於提高診斷成像準確性和減少輻射暴露。受益於政府醫療保健政策和以美國為首的國際合作,加拿大專注於人工智慧和醫學影像的融合,正在製定診斷準確性的新標準。在歐盟(EU),成員國受益於一致的法律規範,並專注於醫學影像的標準化,從而允許大規模的醫療投資來實現一致的高品質護理。同時,中東和非洲 (MEA) 的情況則截然不同。儘管阿拉伯聯合大公國和沙烏地阿拉伯等海灣國家不斷增加的醫療投資正在迅速引進先進的診斷影像系統,但非洲許多地區仍難以獲得此類技術,只能依靠國際援助來填補這一空白。轉向亞太地區,在重大醫療改革和專注於行動和非侵入性成像解決方案的研發部門的推動下,中國正在經歷對醫療成像設備的高消費和需求,並迅速成為一個重要的國家,平衡成長。生產。在政府改善醫療保健和研發投資的支持下,日本在高階醫學成像技術方面表現出色。印度中產階級不斷壯大,健康意識不斷增強,由於政府努力擴大醫療保險覆蓋範圍,以及專注於創新成像解決方案的蓬勃發展的新興企業系統,印度有望成為一個重要的國家。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在醫學影像市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對醫療影像市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在醫學影像市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[190 Pages Report] The Medical Imaging Market size was estimated at USD 54.05 billion in 2023 and expected to reach USD 61.22 billion in 2024, at a CAGR 14.45% to reach USD 139.10 billion by 2030.
The medical imaging market serves as a crucial pillar within healthcare, offering sophisticated techniques for visualizing internal human anatomy, which is vital for diagnostics, treatment, and research. The market growth is propelled by multiple factors: ongoing technological enhancements that improve image quality and system efficiency, an increase in chronic diseases necessitating robust diagnostic solutions, an expanding elderly population demanding frequent healthcare services, and substantial government investments in healthcare infrastructure. However, the medical imaging sector also navigates significant challenges, such as the high costs associated with advanced imaging systems, stringent regulatory landscapes, and concerns over radiation exposure, which may limit patient usage. Ongoing AI integration promises to refine diagnostic precision, the development of portable imaging devices boost accessibility, and advancements in imaging techniques minimize radiation risks, presenting opportunities for market expansion. Hybrid imaging technologies have also emerged as a revolutionary trend, merging multiple imaging modalities to enhance diagnostic efficiency and patient outcomes.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 54.05 billion |
Estimated Year [2024] | USD 61.22 billion |
Forecast Year [2030] | USD 139.10 billion |
CAGR (%) | 14.45% |
Regional Insights
In the Americas region, the United States has a strong emphasis on enhancing imaging precision and reducing radiation exposure, supported by considerable investments in research and development (R&D). Canada's focus on integrating artificial intelligence with medical imaging is setting new standards for diagnostic accuracy, benefiting from governmental healthcare policies and international collaborations, notably with the U.S. Across the European Union, member states benefit from cohesive regulatory frameworks that drive substantial healthcare investments, focusing on standardizing medical imaging to ensure consistent, high-quality care. Meanwhile, the Middle East and Africa (MEA) depict a contrasting scenario; while Gulf countries such as the UAE and Saudi Arabia rapidly incorporate advanced imaging systems due to increased healthcare investments, many African regions still grapple with basic access to these technologies, relying on international aid to bridge the gap. Turning to the Asia-Pacific region, China is rapidly becoming a pivotal country, balancing high consumption with an increasing production of medical imaging equipment, propelled by significant healthcare reforms and a burgeoning R&D sector focusing on mobile and non-invasive imaging solutions. Japan excels in high-end medical imaging technology, supported by substantial governmental healthcare provision and R&D investments. India, with a rising middle class and heightened health awareness, is emerging as a significant market driven by governmental efforts to expand healthcare coverage and a flourishing start-up ecosystem focusing on innovative imaging solutions.
Market Insights
The market dynamics represent an ever-changing landscape of the Medical Imaging Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Medical Imaging Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Medical Imaging Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Clario and Emsere Form Strategic Alliance to Enhance Ophthalmic Clinical Trials
Clario, a company in endpoint solutions for clinical trials, is excited to announce its strategic partnership with Emsere, a renowned supplier of medical equipment. This partnership is set to revolutionize the execution of clinical trials involving ophthalmic imaging and equipment by providing a seamless, integrated solution. Leveraging Emsere's global reach and Clario's extensive trial expertise, the partnership aims to address the equipment scarcity at various trial sites, thereby enhancing the overall trial efficiency. [Published On: 2024-05-21]
Enhancing Medical Innovations, A Collaborative Initiative for Streamlined Access to High-Quality Medical Imaging Data
The U.S. Department of Health and Human Services has launched an innovative partnership through the Advanced Research Projects Agency for Health (ARPA-H) and the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA). This joint initiative aims to develop a Medical Imaging Data Marketplace (MIDM) that would provide widespread access to high-quality and affordable medical imaging data crucial for training Artificial Intelligence (AI) and Machine Learning (ML) in medical diagnostics and treatment tools. [Published On: 2024-03-12]
Philips Unveils Cutting-Edge Medical Imaging Solutions, Enhancing Diagnostic Confidence and Operational Efficiency
Royal Philips introduced several pioneering technologies poised to transform medical imaging practices, emphasizing patient and provider needs. The showcased innovations included advanced ultrasound systems such as EPIQ Elite 10.0 and Philips Affiniti, which integrate sophisticated features in user-friendly designs to aid sonographers in daily practices. Additionally, the revolutionary BlueSeal MR Mobile, mobile MRI unit with helium-free technology is launched, aimed at delivering flexible, patient-centric diagnostic services, while significantly reducing helium consumption as a notable advancement considering the environmental and economic impacts. [Published On: 2023-11-26]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Medical Imaging Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Medical Imaging Market, highlighting leading vendors and their innovative profiles. These include ADLINK Technology Inc., Advantech Co., Ltd., Ampronix, LLC, Aspect Imaging Ltd., Canon Medical Systems Corporation, Carestream Health, Cubresa Inc., EIZO Corporation, ESAOTE SPA, FUJIFILM VisualSonics Inc., GE Healthcare, Hitachi Ltd., Hologic, Inc., Koning Corporation, Koninklijke Philips N.V., Mindray Medical International Limited, MR Solutions Ltd., Olympus Corporation, PerkinElmer Inc., Samsung Healthcare, Shimadzu Corporation, Siemens Healthineers AG, Smith & Nephew PLC, TEAC Corporation, and Ziehm Imaging Inc..
Market Segmentation & Coverage